Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO1020
Host Cell : HEK293T Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO1020 |
| Description | HEK293-LAG3 cell line is engineered to stably overexpress monkey LAG3. |
| Target Gene | LAG3 |
| Host Cell | HEK293T |
| Host Cell Species | Homo sapiens (Human) |
| Applications |
1. Studying the interactions between immune cells and cancer cells 2. Studying the mechanisms of resistance to immune checkpoint blockade 3. High-throughput screening 4. Drug target validation |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
A: Try gradually adapting to low serum conditions or add specific growth factors and supplements to the culture medium to promote cell growth.
A: Optimize protein lysis conditions and antibody selection to enhance protein extraction and immunoprecipitation efficiency, and optimize washing steps to reduce non-specific binding.
A: Cell morphology changes could be a toxic response to the drug. Adjust the drug concentration or use different drug treatment durations to assess its impact on cells.
A: Optimize transfection conditions and components of the CRISPR/Cas9 system, such as sgRNA design and Cas9 protein concentration, to ensure efficient gene editing while minimizing off-target effects.
A: Check and optimize culture conditions, such as medium, temperature, and CO₂ concentration, reduce physical or chemical stress, and consider using cell protectants.
A: Optimize the staining protocol for flow cytometry, such as antibody concentration and incubation time, to ensure cell viability and reduce the impact of cell death on analysis results.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.